BeStock  
Stocks › Biotechnology › STOK

Stoke Therapeutics STOK

US equityMarket cap rank #2926Biotechnology
$25.32 −$0.30 (-1.17%)
Pre-market · Oct 6, 4:10 am ET · After hours $25.32 0.00%
Open$25.82
Prev close$25.62
Day range$24.84 – $26.31
Volume928.4K
Market cap$1.63B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±10.6%last 4 reports
Closed higher3 of 475% of the time
Best reaction+25.0%
Worst reaction-9.9%

Stock move on the day after each report

+25.0%2025/Q2-9.9%2025/Q3+0.3%2026/Q1+7.1%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q23 Aug 2026After Market±10.1%+7.14%Within range
2026/Q17 May 2026After Market±17.5%+0.31%Within range
2025/Q34 Nov 2025After Market±20.9%-9.94%Within range
2025/Q212 Aug 2025After Market–+24.98%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Fundamentals

Full statements →

Latest reported quarter: Q2, ended Jun 2026

Revenue$9.33M-32.5% YoY
Operating profit-$65.43M-139.7% YoY
Net profit-$61.62M-162.4% YoY
Diluted EPS-$0.93-132.5% YoY

Revenue, last 8 quarters

$4.9MSep '24$22.6MDec '24$158.6MMar '25$13.8MJun '25$10.6MSep '25$1.4MDec '25$6.2MMar '26$9.3MJun '26

Net profit, last 8 quarters

$-26.4MSep '24$-10.5MDec '24$112.9MMar '25$-23.5MJun '25$-38.3MSep '25$-57.9MDec '25$-50.0MMar '26$-61.6MJun '26

Profitability & balance sheet

Operating margin-809.7%
Net margin-753.6%
Return on equity-61.1%
Return on assets-53.4%
Return on invested capital-60.7%
Current ratio7.69

Discussion

No comments yet — be the first to weigh in on STOK.

Leave a comment

Scroll to Top